Functional Imaging Reserve in NeuroHIV



Status:Recruiting
Conditions:HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:20 - 80
Updated:2/17/2019
Start Date:November 20, 2018
End Date:July 31, 2023
Contact:John Doyle, MA
Email:doylej@wustl.edu
Phone:3147471072

Use our guide to learn which trials are right for you!

The purpose of this research study is to look at the brain's efficiency and ability to make
up for deficits in the front of the brain to see if people living with HIV (PLWH) are still
able to perform well on various cognitive tasks even though there are other underlying
processes at work, like inflammation, that affect the brain in a negative way. Results of
this study may provide insight into the pathophysiology of disease and may reveal arenas for
future possible interventions in PLWH who have impaired neuropsychological performance.

This proposal systematically characterizes brain efficiency and recruitment in virologically
suppressed persons living with HIV (PLWH) and demographically similar HIV uninfected (HIV-)
controls. This proposal collects advanced functional neuroimaging that provide critical
information about cerebral blood flow (CBF) and brain connectivity (functional connectivity
strength; FCS); quantitative measures of immune dysfunction in the blood and cerebrospinal
fluid (CSF) (immune activation and immune exhaustion); and neuropsychological performance
testing. This overall goal of this proposal is to delineate the interplay between dysfunction
in frontal networks and recruitment of compensatory networks that underlie the
neuropsychiatric symptoms seen in PLWH.

Inclusion Criteria:

- 20 to 80 years old

- documented HIV infection for at least 1 year or confirmed HIV - status

- PLWH must be on stable cART regimen for at least 12 months with undetectable plasma
HIV RNA (less than 50 copies per mL)

- at least 9 years of education

- able to provide informed consent

- if female, a negative pregnancy test and not breast feeding

- able to undergo an MRI scan

Exclusion Criteria:

- significant neurological disorders (e.g. stroke, head injury with loss of
consciousness for more than 5 minutes, developmental learning disability)

- active uncontrolled Axis I psychiatric disorder according to the DSM 5

- current or history of substance use disorder (including, but not limited to
amphetamines, cocaine, alcohol, opiates, and barbiturates)

- prescribed blood thinners

- allergic to lidocaine or similar anesthetic

- history of any bleeding disorder

- contraindication to MRI scanning (e.g. claustrophobia, pacemaker, etc.)

- pregnant or breastfeeding
We found this trial at
1
site
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Principal Investigator: Beau M Ances, MD, PhD
Phone: 314-747-1072
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials